1. Home
  2. NEO vs VYX Comparison

NEO vs VYX Comparison

Compare NEO & VYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEO
  • VYX
  • Stock Information
  • Founded
  • NEO 2001
  • VYX 1881
  • Country
  • NEO United States
  • VYX United States
  • Employees
  • NEO N/A
  • VYX N/A
  • Industry
  • NEO Precision Instruments
  • VYX
  • Sector
  • NEO Health Care
  • VYX
  • Exchange
  • NEO Nasdaq
  • VYX Nasdaq
  • Market Cap
  • NEO 1.2B
  • VYX 1.1B
  • IPO Year
  • NEO 1999
  • VYX N/A
  • Fundamental
  • Price
  • NEO $9.55
  • VYX $7.80
  • Analyst Decision
  • NEO Strong Buy
  • VYX Strong Buy
  • Analyst Count
  • NEO 10
  • VYX 6
  • Target Price
  • NEO $19.44
  • VYX $15.17
  • AVG Volume (30 Days)
  • NEO 1.9M
  • VYX 2.4M
  • Earning Date
  • NEO 04-29-2025
  • VYX 05-08-2025
  • Dividend Yield
  • NEO N/A
  • VYX N/A
  • EPS Growth
  • NEO N/A
  • VYX N/A
  • EPS
  • NEO N/A
  • VYX 6.52
  • Revenue
  • NEO $660,566,000.00
  • VYX $2,826,000,000.00
  • Revenue This Year
  • NEO $13.06
  • VYX N/A
  • Revenue Next Year
  • NEO $11.18
  • VYX N/A
  • P/E Ratio
  • NEO N/A
  • VYX $1.15
  • Revenue Growth
  • NEO 11.65
  • VYX N/A
  • 52 Week Low
  • NEO $8.05
  • VYX $7.67
  • 52 Week High
  • NEO $19.11
  • VYX $15.34
  • Technical
  • Relative Strength Index (RSI)
  • NEO 48.48
  • VYX 32.33
  • Support Level
  • NEO $8.05
  • VYX $7.74
  • Resistance Level
  • NEO $10.18
  • VYX $8.48
  • Average True Range (ATR)
  • NEO 0.72
  • VYX 0.56
  • MACD
  • NEO 0.16
  • VYX -0.05
  • Stochastic Oscillator
  • NEO 70.42
  • VYX 5.70

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

About VYX NCR Voyix Corporation

NCR Voyix Corp is a company providing services of digital commerce solutions for retail, restaurant, and digital banking. The company operates in three reportable segments: Retail, Restaurants, and Digital Banking. The Retail segment provides software solutions for retailers of all sizes, enhancing operational efficiency and customer experience. The Restaurants segment offers end-to-end technology solutions for food service establishments, improving operational efficiency, and customer satisfaction, and reducing costs. The Digital Banking segment serves financial institutions with cloud-based software solutions for a fully integrated digital banking experience across channels. Revenue sources include software sales and service support within each segment.

Share on Social Networks: